Horizon Pharma (HZNP) PT Lowered to $20 at Cowen; Valuation Suggests Investors Step in Here
Tweet Send to a Friend
Cowen lowered its price target on Horizon Pharma (NASDAQ: HZNP) to $20.00 (from $42.00), but maintained an Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
